Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-γ Mice

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Chen, Xin ^a,b   Liu, Bigang ^a   Li, Qiuhui ^a,c   Honorio, Sofia ^a   Liu, Xin ^a,d   Liu, Can ^a,b   Multani, Asha S ^e   Calhoun Davis, Tammy ^a   Tang, Dean G ^a,b,e,f  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CYTOKERATIN 8; EPITHELIAL CELL ADHESION MOLECULE; MATRIGEL; RACEMASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CARCINOGENICITY; CELL IMMORTALIZATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; EPITHELIUM CELL; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PROSTATE CANCER; SCID MOUSE; STROMA CELL; XENOTRANSPLANTATION;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84874336543     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056903     Document Type: Article

References (71)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
3. Patrawala L, Calhoun T, Schneider-Broussard R. Zhou J-J, Claypool K, et al. (2005) Side population (SP) is enriched in tumorigenic, stem-like cancer cells whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65: 6207-6219.
4. Huss WJ, Gray DR, Greenberg NM, Mohler JL, Smith GJ, (2005) Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res 65: 6640-6650.
5. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
6. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, et al. (2006) Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708.
7. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG, (2007) Hierarchical organization of prostate cancer cells in xenograft tumors: The CD44+α2β1+ cell population is enriched in tumor-initiating cells. Cancer Res 67: 6796-6805.
8. Miki J, Furusato B, Li H, Gu Y, Takahashi H, et al. (2007) Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67: 3153-3161.
9. Gu G, Yuan J, Wills M, Kasper S, (2007) Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 67: 4807-4815.
10. Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, et al. (2007) Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol Carcinog 46: 1-14.
11. Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG, (2008) PC3 Human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 68: 1820-1825.
12. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL, (2008) CD44+CD24- prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98: 756-765.
13. Jeter C, Badeaux M, Choy G, Chandra D, Patrawala L, et al. (2009) Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27: 993-1005.
14. Li H, Jiang M, Honorio S, Patrawala L, Jeter C, et al. (2009) Methodologies in assaying prostate cancer stem cells. Methods Mol Biol 569: 85-138.
15. Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, et al. (2009) The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 106: 268-273.
16. Guzmán-Ramírez N, Völler M, Wetterwald A, Germann M, Cross NA, et al. (2009) In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate 69: 1683-1693.
17. Li T, Su Y, Mei Y, Leng Q, Leng B, et al. (2010) ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Lab Invest 90: 234-244.
18. Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, et al. (2009) Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis 26: 433-446.
19. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, et al. (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70: 5163-5173.
20. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI, (2011) Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling. Nat Commun 2: 162.
21. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, et al. (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17: 211-215.
22. Jeter CR, Liu B, Liu X, Chen X, Liu C, et al. (2011) NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30: 3833-3845.
23. Kobayashi A, Okuda H, Xing F, Pandey PR, Watabe M, et al. (2011) Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med 208: 2641-2655.
24. Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, et al. (2012) Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res 72: 1878-1889.
25. Qin J, Liu X, Laffin B, Chen X, Choy G, et al. (2012) The PSA-/lo prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10: 556-569.
26. Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, et al. (2012) Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. J Urol 188: 294-299.
27. Germann M, Wetterwald A, Guzmán-Ramirez N, van der Pluijm G, Culig Z, et al. (2012) Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer. Stem Cells 30: 1076-1086.
28. Colombel M, Eaton CL, Hamdy F, Ricci E, van der Pluijm G, et al. (2012) Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases. Prostate 72: 713-720.
29. Dubrovska A, Elliott J, Salamone RJ, Telegeev GD, Stakhovsky AE, et al. (2012) CXCR4 expression in prostate cancer progenitor cells. PLoS One 7: e31226.
30. Mimeault M, Johansson SL, Batra SK, (2012) Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies. PLoS One 7: e31919.
31. Liu C, Kelnar K, Vlassov AV, Brown D, Wang J, et al. (2012) Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res 72: 3393-3404.
32. Zhou J, Wang H, Cannon V, Wolcott KM, Song H, et al. (2011) Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells. Mol Cancer 10: 112.
33. Tang DG, (2012) Understanding cancer stem cell heterogeneity and plasticity. Cell Res 22: 457-472.
34. Shen MM, Abate-Shen C, (2010) Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 24: 1967-2000.
35. Céspedes MV, Casanova I, Parreño M, Mangues R, (2006) Mouse models in oncogenesis and cancer therapy. Clin Transl Oncol 8: 318-329.
36. Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, et al. (1996) Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin Cancer Res 2: 1039-1048.
37. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, et al. (1997) Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 3: 402-408.
38. Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, et al. (2003) LuCaP 35: a new model of prostate cancer progression to androgen independence. Prostate 55: 239-246.
39. Pienta KJ, Abate-Shen C, Agus DB, Attar RM, Chung LW, et al. (2008) The current state of preclinical prostate cancer animal models. Prostate 68: 629-639.
40. Penson D, Chan J, (2007) Prostate cancer. In: NIH publication Litwin MS, Saigal CS, editors. Urological Diseases in America. DHHS, PHS, NIH, NIDDK. Washington, D.C.: GPO. 07-5512: 71-120.
41. Priolo C, Agostini M, Vena N, Ligon AH, Fiorentino M, et al. (2010) Establishment and genomic characterization of mouse xenografts of human primary prostate tumors. Am J Pathol 176: 1901-1913.
42. Zhao H, Nolley R, Chen Z, Peehl DM, (2010) Tissue Slice Grafts. An in vivo Model of Human Prostate Androgen Signaling. Am J Pathol 177: 229-239.
43. Toivanen R, Berman DM, Wang H, Pedersen J, Frydenberg M, et al. (2011) Brief report: a bioassay to identify primary human prostate cancer repopulating cells. Stem Cells 29: 1310-1314.
44. Roecklein BA, Torok-Storb B, (1995) Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood 85: 997-1005.
45. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, et al. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011.
46. Silvers CR, Williams K, Salamone L, Huang J, Jordan CT, et al. (2010) A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors. Prostate 70: 1379-1387.
47. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
48. Cunha GR, Lung B, (1978) The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J Exp Zool 205: 181-193.
49. Leong KG, Wang BE, Johnson L, Gao WQ, (2008) Generation of a prostate from a single adult stem cell. Nature 456: 804-808.
50. Hayward SW, Haughney PC, Rosen MA, Greulich KM, Weier HU, et al. (1998) Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 63: 131-140.
51. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, et al. (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 61: 8135-8142.
52. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563.
53. O'Connor JC, Farach-Carson MC, Schneider CJ, Carson DD, (2007) Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells. Mol Cancer Res 5: 585-603.
54. Delk NA, Farach-Carson MC, (2012) Interleukin-6: A bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells. Autophagy 8: 650-663.
55. Lacombe L, Orlow I, Reuter VE, Fair WR, Dalbagni G, et al. (1996) Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. Int J Cancer 69: 110-113.
56. Li J, Yen C, Liaw D, Podsypanina K, Bose S, et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
57. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, et al. (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362.
58. Garber K, (2009) From human to mouse and back: "tumorgraft" models surge in popularity. J Natl Cancer Inst 101: 6-8.
59. Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, et al. (2005) Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate 64: 149-159.
60. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, et al. (2003) Molecular characterization of human prostate carcinoma cell lines. Prostate 57: 205-225.
61. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344.
62. Schwab TS, Stewart T, Lehr J, Pienta KJ, Rhim JS, et al. (2000) Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell cultures. Prostate 44: 164-171.
63. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON, (2010) Identification of a cell of origin for human prostate cancer. Science 329: 568-571.
64. Goldstein AS, Drake JM, Burnes DL, Finley DS, Zhang H, et al. (2011) Purification and direct transformation of epithelial progenitor cells from primary human prostate. Nat Protoc 6: 656-667.
65. DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, et al. (2011) Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 17: 1514-1520.
66. Pretlow TG, Delmoro CM, Dilley GG, Spadafora CG, Pretlow TP, (1991) Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res 51: 3814-3817.
67. Bhatia B, Multani AS, Patrawala L, Chen X, Calhoun-Davis T, et al. (2008) Evidence that senescent human prostate epithelial cells enhance tumorigenicity: Cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT. Int J Cancer 122: 1483-1495.
68. Placencio VR, Li X, Sherrill TP, Fritz G, Bhowmick NA, (2010) Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth. PLoS One 5: e12920.
69. Wang R, Sun X, Wang CY, Hu P, Chu CY, et al. (2012) Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression. PLoS One 7: e42653.
70. Chung LW, Chang SM, Bell C, Zhau HE, Ro JY, et al. (1989) Co-inoculation of tumorigenic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals. Int J Cancer 43: 1179-1187.
71. Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, et al. (2012) Suppression of acquired docetaxel resistance in prostate cancer through depletion of Notch- and Hedgehog-dependent tumor-initiating cells. Cancer Cell 22: 373-388.